Article Versions Notes

Schwertheim S, Alhardan M, Manka PP, Sowa J-P, Canbay A, Schmidt HH-J, Baba HA, Kälsch J. Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. Journal of Personalized Medicine. 2023; 13(7):1152. https://doi.org/10.3390/jpm13071152

Schwertheim, Suzan, Malek Alhardan, Paul P. Manka, Jan-Peter Sowa, Ali Canbay, Hartmut H.-J. Schmidt, Hideo A. Baba, and Julia Kälsch. 2023. "Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels" Journal of Personalized Medicine 13, no. 7: 1152. https://doi.org/10.3390/jpm13071152

Schwertheim, S., Alhardan, M., Manka, P. P., Sowa, J.-P., Canbay, A., Schmidt, H. H.-J., Baba, H. A., & Kälsch, J. (2023). Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. Journal of Personalized Medicine, 13(7), 1152. https://doi.org/10.3390/jpm13071152